Medtronic 670G Insulin Pump and the Impact on Glycemic Control, Quality of Life, and Compliance

Last updated: March 31, 2020
Sponsor: Metabolic Research Institute, Inc.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes Mellitus, Type 1

Treatment

N/A

Clinical Study ID

NCT04329871
MetabolicRI
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Analyze the Medtronic 670g pump on glycemic control

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age 18 or older

  • Documented History of Type 1 Diabetes Mellitus

  • 3 months continuous use of the Medtronic 670g pump system

  • given written informed consent

Exclusion

Exclusion Criteria:

  • Less than 3 months use of the Medtronic 670g pump system

  • Taking any other medication, other than the insulin used in the Medtronic 670g pump,to manage their diabetes

  • having medical conditions or taking medications that would preclude subjectinvolvement or affect the outcomes being measured, in the opinion of the Investigator

Study Design

Total Participants: 100
Study Start date:
March 24, 2020
Estimated Completion Date:
March 23, 2021

Study Description

An Analysis of the Medtronic 670g Insulin pump use in clinical practice and the impact on glycemic control , quality of life, and compliance

Connect with a study center

  • Metabolic Research Institute

    West Palm Beach, Florida 33401
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.